1. Anticancer Effects of a Korean Herbal Medicine Formula (H9) via AMPK and HER2-PI3K/Akt Signaling in Breast Cancer Cells
   Ju-Hee Lee et al, 2017, Phytother. Res. CrossRef
2. Triple negative breast cancer: emerging therapeutic modalities and novel combination therapies
   Alice Lee et al, 2017, Cancer Treatment Reviews CrossRef
3. The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts
   Michael Mc Kenna et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
4. Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO)
   Faranak Alipour et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
5. NVP-BKM120 inhibits colon cancer growth via FoxO3a-dependent PUMA induction
   Shida Yang et al, 2017, Oncotarget CrossRef
6. Dual or multiple drug loaded nanoparticles to target breast cancer stem cells
   Yu Gao et al, 2020, RSC Adv. CrossRef
7. Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy.
   Valdenizia R Silva et al, 2020, Cancers (Basel) CrossRef
8. Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer
   Manzoor A. Mir et al, 2020, CCDT CrossRef
9. Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
   Li Lv et al, 2021, IJN CrossRef
10. HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness
    Serenella M. Pupa et al, 2021, Cancers CrossRef
11. Cancer stem cell‐targeted therapeutic approaches for overcoming trastuzumab resistance in HER2‐positive breast cancer
    Yan Qiu et al, 2021, Stem Cells CrossRef
12. Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling
    Ruhainee Tohkayomatee et al, 2022, Molecules CrossRef
13. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications
    Lei Wang et al, 2022, Cancers CrossRef
14. Nanomedicine for targeting breast cancer stem cells
    Valamla Bhavana et al, 2022 CrossRef
15. A Review of Biological Targets and Therapeutic Approaches in the Management of Triple-Negative Breast Cancer
    Hitesh Kumar et al, 2023, Journal of Advanced Research CrossRef
16. CTTN Overexpression Confers Cancer Stem Cell-like Properties and Trastuzumab Resistance via DKK-1/WNT Signaling in HER2 Positive Breast Cancer
    So-Jeong Moon et al, 2023, Cancers CrossRef
17. Therapeutic strategies for targeting cancer stem cells
    N. S Alkon et al, 2018, Genes & Cells CrossRef